Latest Breaking News On - Accustem sciences - Page 7 : comparemela.com

Tiziana Life Sciences : Distribution Dates for shares and ADRs in Accustem Sciences Limited (Form 6-K)

Tiziana Life Sciences : Distribution Dates for shares and ADRs in Accustem Sciences Limited (Form 6-K)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomCity ofTiziana adssGabriele cerroneLondon stock exchangeTiziana life sciencesJp morganRedchip companies incAdrs in accustem sciencesAccustem sciencesDistribution datesAccustem sciences limitedLife sciencesRecord time

Tiziana Life Sciences Plc: Tiziana Life Sciences plc Announces Plans to List Accustem Sciences Limited in the U S

(0) NEW YORK and LONDON, April 13, 2021 (GLOBE NEWSWIRE) Tiziana Life Sciences plc (NASDAQ:TLSA; LSE: TILS), today announced that its former subsidiary, Accustem Sciences Limited ( Accustem ), intends to file a listing application with the Nasdaq Stock Market shortly after completion of the distribution of shares in Accustem to Tiziana Life Sciences plc shareholders. The board of directors of Accustem has resolved that the Nasdaq listing venue is more appropriate to the nature of Accustem s business. About Accustem Sciences StemPrintER is a multi-gene prognostic assay intended to predict the risk of recurrence of R+/HER2- breast cancer, and Spare, a derivative of StemPrintER, combines StemPrintER with two clinical markers. This gives a more refined risk model.

United statesUnited kingdomCity ofGabriele cerroneTiziana life sciences plc adr aktieAccustem to tiziana life sciencesAmerican society of clinical oncologyAccustem sciences limitedTiziana life sciencesRedchip companies incAccustem sciencesLife sciencesNasdaq stock marketAmerican societyClinical oncologyVirtual conference

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) - The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche s Asthma Drug

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) - The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche s Asthma Drug
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Innovent biologicsKarim mikhailJohn theroEli lillyGain therapeutics incSystems incAuris medical holding ltdCelcuity incMimedx group incCenters for diseaseLife sciences corpDrug administrationTiziana life sciencesAmarin corporationLiquidia corporationBurning rock biotech limited

Investegate |OKYO Pharma Limited Announcements | OKYO Pharma Limited: Directorate Change

7 January 2021 OKYO Pharma Limited ( OKYO or the Company ) today announces that Gabriele Cerrone has been appointed as a non-executive chairman of the company and Dr Gary S. Jacob has been appointed as Chief Executive Officer and director of the company, both with immediate effect. Gabriele Cerrone (age: 48) Mr Cerrone has a successful track record and extensive experience in the financing and restructuring of micro-cap biotechnology companies. He has founded ten biotechnology companies in oncology, infectious diseases and molecular diagnostics, and has taken seven of these companies to the NASDAQ Market and two to the Main Market and AIM Market in London. Mr Cerrone is Executive Chairman of dual listed Tiziana Life Sciences plc. Mr Cerrone co-founded Cardiff Oncology, Inc. (NASDAQ: CRDF), an oncology company and served as its Co-Chairman; he was a co-founder and served as Chairman of both Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) and Callisto Pharmaceutical

United statesUnited kingdomCity ofRobert emmetGabriele cerroneGarys jacobWilly simonMonsanto gd searleSiga technologies incFounder of hepion pharmaceuticals incPharma limitedFounder of tiziana life sciencesSynergy pharmaceuticalsBausch health incUniversity of missouriOptiva securities